Abstract
Background
Patients undergoing general anesthesia for laparoscopic cholecystectomy are at high risk for postoperative nausea and vomiting (PONV). This study compared ramosetron and ondansetron in terms of efficacy for PONV prevention after laparoscopic cholecystectomy.
Methods
For this study, 120 patients scheduled to undergo laparoscopic cholecystectomy were randomized (in double-blind fashion) to receive 4 mg of ondansetron (group O4, n = 40), 8 mg of ondansetron (group O8, n = 40), or 0.3 mg of ramosetron (group R, n = 40) intravenously after surgery. Postoperative nausea, retching, vomiting, pain, and side effects were assessed at 2 h, 24 h, and 48 h after surgery.
Results
No statistical differences were observed among the three groups with regard to patient characteristics and information on surgery and anesthesia. The ratio of complete response (no PONV for 2 h) was higher for groups O8 and R than for group O4 as follows: 80% (n = 32) for groups O8 and R versus 58% (n = 23) for group O4 during the first postoperative 2 h (p = 0.04), 90% (n = 36) for groups O8 and R versus 76% (n = 30) for group O4 over 24 h (2–24 h) (p = 0.09), and 98% (n = 38) for groups O4 and O8 versus 100% (n = 40) for group R over the next 24 h (24–48 h) after surgery (p = 0.36). During the first 2 h after surgery, rescue antiemetics were used for significantly fewer patients in groups O8 and R (20%) than in group O4 (42.5%) (p = 0.04). Postoperative pain and the use of rescue analgesics were comparable among the groups. There was no clinically serious adverse event due to the study drugs.
Conclusion
Ramosetron 0.3 mg and ondansetron 8 mg are more effective than ondansetron 4 mg for the prevention of PONV (2 h). Ramosetron 0.3 mg is as effective as ondansetron 8 mg for the prophylaxis of PONV after laparoscopic cholecystectomy.
Similar content being viewed by others
References
Watcha MF, White PF (1992) Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 77:161–184
Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramèr MR, Watcha M (2003) Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 97:62–71
Stadler M, Bardiau F, Seidel L, Albert A, Boogaerts JG (2003) Difference in risk factors for postoperative nausea and vomiting. Anesthesiology 98:46–52
Tramer MR (2004) Strategies for postoperative nausea and vomiting. Best Pract Res Clin Anaesthesiol 18:693–701
Fujii Y (2005) The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy. Curr Pharmaceut Des 11:3173–3183
Nesek-Adam V, Grizelj-Stojcic E, Rasic Z, Cala Z, Mrsic V, Smiljanic A (2007) Comparison of dexamethasone, metoclopramide, and their combination in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Surg Endosc 21:607–612
Santon JM (1991) Anaesthesia for laparoscopic cholecystectomy. Anaesthesia 46:317
Thune A, Appelgren L, Haglind E (1995) Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a prospective randomized study of metoclopramide and transdermal hyoscine. Eur J Surg 161:265–268
Sohi HS, Heipel J, Inman KJ, Chinnick B, Cunningham DG, Holliday RL, Girotti MJ (1994) Preoperative transdermal scopolamine does not reduce the level of nausea and frequency of vomiting after laparoscopic cholecystectomy. Can J Surg 37:307–312
Kothari SN, Boyd WC, Bottcher ML, Lambert PJ (2000) Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial of inpatients undergoing laparoscopic cholecystectomy. Surg Endosc 14:926–929
Parlow JL, Meikle AT, van Vlymen J, Avery N (1999) Postdischarge nausea and vomiting after ambulatory laparoscopy is not reduced by promethazine prophylaxis. Can J Anaesth 46:719–724
Fujii Y, Tanaka H, Toyooka H (1999) Prophylactic antiemetic therapy with droperidol in patients undergoing laparoscopic cholecystectomy. J Anesth 13:140–143
Leksowski K, Peryga P, Szyca R (2006) Ondansetron, metoclopramid, dexamethasone, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study. Surg Endosc 20:878–882
Morgan GE, Mikhail MS, Murray MJ (2002) Adjuncts to anesthesia. In: Morgan GE, Mikhail MS, Murray MJ (eds) Clinical anesthesiology. McGraw-Hill, New York, pp 242–252
Hesketh PJ, Gandara DR (1991) Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 83:613–620
Tramer MR, Moore RA, Reynolds DJ, McQuay HJ (1997) A quantitative systematic review of ondansetron in the treatment established postoperative nausea and vomiting. Anesthesiology 314:1088–1089
Helmy SA (1999) Prophylactic antiemetic efficacy of ondansetron in laparoscopic cholecystectomy under total intravenous anaesthesia: a randomised, double-blind comparison with droperidol, metoclopramide and placebo. Anaesthesia 54:266–270
Naguib M, el Bakry AK, Khoshim MH, Channa AB, el Gammal M, el Gammal K, Elhattab YS, Attia M, Saddique A (1996) Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron, and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo. Can J Anaesth 43:226–231
Shi Y, He X, Yang S, Ai B, Zhang C, Huang D, Dong M, Liu P, Zhou S, Han X (2007) Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: a prospective randomized controlled study. Chemotherapy 53:44–50
Kang YK, Park YH, Ryoo BY, Bang YJ, Cho KS, Shin DB, Kim HC, Lee KH, Park YS, Lee KS, Heo DS, Kim SY, Cho EK, Lim HY, Kim WK, Lee JA, Kim TY, Lee JC, Yoon HJ, Kim NK (2002) Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron. J Int Med Res 30:220–229
Fujii Y, Tanaka H (2002) Comparison of granisetron and ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 24:766–772
Fujii Y, Tanaka H (2002) Double-blind, placebo-controlled, dose-ranging study of ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 24:1148–1153
Fujii Y, Uemura A, Tanaka H (2002) Prophylaxis of nausea and vomiting after laparoscopic cholecystectomy with ramosetron: randomised controlled trial. Eur J Surg 168:583–586
Quaynor H, Raeder JC (2002) Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies. Acta Anaesthesiol Scand 46:109–113
Grond S, Lynch J, Diefenbach C, Altrock K, Lehmann KA (1995) Comparison of ondansetron and droperidol in the prevention of nausea and vomiting after inpatient minor gynecologic surgery. Anesth Analg 81:603–607
Honkavaara P (1996) Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth 76:316–318
Paventi S, Santevecchi A, Ranieri R (2001) Efficacy of a single-dose ondansetron for preventing postoperative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia. Eur Rev Med Pharmacol Sci 5:59–63
Fujii Y, Tanaka H, Somekawa Y (2004) A randomized, double-blind, placebo-controlled trial of ramosetron for preventing nausea and vomiting during termination of pregnancy. Int J Obstet Anesth 13:15–18
Fujii Y, Saitoh Y, Tanaka H, Toyooka H (2000) Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery. Anesth Analg 90:472–475
Gepstein R, Arinzon Z, Folman Y, Shuval I, Shabat S (2007) Efficacy and complications of patient-controlled analgesia treatment after spinal surgery. Surg Neurol 67:360–366
Papadimitriou L, Livanios S, Katsaros G, Hassiakos D, Koussi T, Demesticha T (2001) Prevention of postoperative nausea and vomiting after laparoscopic gynaecological surgery: combined antiemetic treatment with tropisetron and metoclopramide vs metoclopramide alone. Eur J Anaesthesiol 18:615–619
Sanchez-Ledesma MJ, Lopez-Olaondo L, Pueyo FJ, Carrascosa F, Ortega A (2002) A comparison of three antiemetic combinations for the prevention of postoperative nausea and vomiting. Anesth Analg 95:1590–1595
Biswas BN, Rudra A (2003) Comparison of granisetron and granisetron plus dexamethasone for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Acta Anaesthesiol Scand 47:79–83
Coloma M, White PF, Markowitz SD, Whitten CW, Macaluso AR, Berrisford SB, Thornton KC (2002) Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy. Anesthesiology 96:1346–5130
Caldwell CB, Ricotta JJ (1987) Changes in visceral blood flow with elevated intraabdominal pressure. J Surg Res 43:14–20
Diebel LN, Dulchavsky SA, Wilson RF (1992) Effect of increased intraabdominal pressure on mesenteric arterial and intestinal mucosal blood flow. J Trauma 33:45–48
Goll V, Akça O, Greif R, Freitag H, Arkiliç CF, Scheck T, Zoeggeler A, Kurz A, Krieger G, Lenhardt R, Sessler DI (2001) Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesth Analg 92:112–117
Fujii Y, Saitoh Y, Tanaka H, Toyooka H (1999) Ramosetron vs granisetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 46:991–993
Choi YS, Shim JK, Yoon do H, Jeon DH, Lee JY, Kwak YL (2008) Effect of ramosetron on patient-controlled analgesia-related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. Spine 33:E602–E606
Hartung J (1996) Twenty-four of twenty-seven studies show a greater incidence of emesis with nitrous oxide than with alternative anesthetics. Anesth Analg 83:114–116
Tramer M, Moore A, McQuay H (1996) Omitting nitrous oxide in general anesthesia: meta-analysis of intraoperative, awareness, and postoperative emesis in randomized controlled trials. Br J Anaesth 76:186–193
Rosow CE (1999) An overview of remifentanil. Anesth Analg 89:S1–S3
Glass PS, Gan TJ, Howell S (1999) A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 89:S7–S14
Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL (1995) Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83:968–975
Song D, White PF (1999) Remifentanil as an adjuvant during desflurane anesthesia facilitates early recovery after ambulatory surgery. J Clin Anesth 11:364–367
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ryu, J., So, YM., Hwang, J. et al. Ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Surg Endosc 24, 812–817 (2010). https://doi.org/10.1007/s00464-009-0670-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-009-0670-5